Thursday, 18 Oct 2018

You are here

Kevin Winthrop, MD: H. zoster and tofacitinib: the risk of concomitant nonbiologic therapy

Dr. Kevin Winthrop, associate professor of infectious diseases at Oregon Health & Sciences University in Portland, Oregon, discusses abstract 559.

Add new comment

Want to talk about this video? Comment here to lead the discussion.
MORE VIDEOS

The RheumNow Week in Review – 28 July...

28 Jul 2017

The ACR17 RheumNow Week in Review - 1...

01 Dec 2017

Dr. Julio Gonzalez: Psoriatic Arthritis...

07 Nov 2017

Dr. George Martin: New Molecular...

11 Feb 2018

Dr. Rachel Tate: IgG4 Mimics

06 Feb 2017

RheumNow Week in Review – 4 November...

04 Nov 2016

Dr. Arthur Lau: FRAME Study

14 Nov 2016

Dr. Arthur Kavanaugh: The Great Debate

14 Nov 2016

The RheumNow Week in Review – EULAR18...

22 Jun 2018

Dr. Elaine Alexander: Kikuchi-Fujimoto...

09 Feb 2018

Dr. Chad Deal: 2015 Workforce Study

14 Nov 2016

The RheumNow Week in Review – Good News...

01 Jun 2018